Barfresh Food Group, Inc.

NasdaqCM:BRFH Stock Report

Market Cap: US$41.0m

Barfresh Food Group Valuation

Is BRFH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BRFH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BRFH's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BRFH's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BRFH?

Key metric: As BRFH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BRFH. This is calculated by dividing BRFH's market cap by their current revenue.
What is BRFH's PS Ratio?
PS Ratio4.2x
SalesUS$9.85m
Market CapUS$40.99m

Price to Sales Ratio vs Peers

How does BRFH's PS Ratio compare to its peers?

The above table shows the PS ratio for BRFH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.2x
FARM Farmer Bros
0.1x4.6%US$41.5m
2.9xn/aUS$25.1m
HUAK Huake Holding Biology
1.5xn/aUS$31.3m
BRID Bridgford Foods
0.3xn/aUS$80.3m
BRFH Barfresh Food Group
4.2x29.2%US$41.0m

Price-To-Sales vs Peers: BRFH is expensive based on its Price-To-Sales Ratio (4.2x) compared to the peer average (1.1x).


Price to Sales Ratio vs Industry

How does BRFH's PS Ratio compare vs other companies in the US Food Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
BG Bunge Global
0.2x3.5%US$12.50b
DOLE Dole
0.2x0.7%US$1.40b
FARM Farmer Bros
0.1x4.6%US$41.47m
BHIL Benson Hill
0.06xn/aUS$29.02m
BRFH 4.2xIndustry Avg. 0.9xNo. of Companies27PS012345+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: BRFH is expensive based on its Price-To-Sales Ratio (4.2x) compared to the US Food industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is BRFH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BRFH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.2x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: BRFH is expensive based on its Price-To-Sales Ratio (4.2x) compared to the estimated Fair Price-To-Sales Ratio (0.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BRFH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$2.78
US$5.25
+88.8%
14.3%US$6.00US$4.50n/a2
Nov ’25US$2.53
US$5.25
+107.5%
14.3%US$6.00US$4.50n/a2
Oct ’25US$2.71
US$5.25
+93.5%
14.3%US$6.00US$4.50n/a2
Sep ’25US$3.60
US$5.25
+45.8%
14.3%US$6.00US$4.50n/a2
Aug ’25US$3.80
US$4.50
+18.4%
33.3%US$6.00US$3.00n/a2
Mar ’25US$1.22
US$4.25
+248.4%
29.4%US$5.50US$3.00n/a2
Feb ’25US$1.26
US$4.75
+276.4%
15.8%US$5.50US$4.00n/a2
Jan ’25US$1.59
US$4.75
+198.7%
15.8%US$5.50US$4.00n/a2
Dec ’24US$1.65
US$4.75
+187.9%
15.8%US$5.50US$4.00n/a2
Nov ’24US$1.66
US$4.75
+186.1%
15.8%US$5.50US$4.00US$2.532
Oct ’24US$1.91
US$4.75
+148.7%
15.8%US$5.50US$4.00US$2.712
Sep ’24US$1.98
US$4.75
+139.9%
15.8%US$5.50US$4.00US$3.602
Aug ’24US$1.55
US$4.75
+206.5%
15.8%US$5.50US$4.00US$3.802
Jul ’24US$1.50
US$4.75
+216.7%
15.8%US$5.50US$4.00US$3.622
Jun ’24US$1.30
US$4.75
+265.4%
15.8%US$5.50US$4.00US$1.692
May ’24US$1.29
US$4.75
+268.2%
15.8%US$5.50US$4.00US$1.932
Apr ’24US$1.38
US$4.75
+244.2%
15.8%US$5.50US$4.00US$1.102
Mar ’24US$1.25
US$5.25
+320.0%
4.8%US$5.50US$5.00US$1.222
Feb ’24US$1.46
US$5.25
+259.6%
4.8%US$5.50US$5.00US$1.262
Jan ’24US$1.30
US$5.25
+303.8%
4.8%US$5.50US$5.00US$1.592
Dec ’23US$1.25
US$5.25
+320.0%
4.8%US$5.50US$5.00US$1.652
Nov ’23US$1.87
US$10.50
+461.5%
23.8%US$13.00US$8.00US$1.662

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies